nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—CYP2D6—Hydroxyurea—head and neck cancer	0.113	0.738	CbGbCtD
Quinidine barbiturate—Folate deficiency—Hydroxyurea—head and neck cancer	0.0833	0.101	CcSEcCtD
Quinidine barbiturate—CYP2D6—Vinblastine—head and neck cancer	0.0398	0.261	CbGbCtD
Quinidine barbiturate—Anaemia megaloblastic—Hydroxyurea—head and neck cancer	0.0295	0.0359	CcSEcCtD
Quinidine barbiturate—Cardiotoxicity—Fluorouracil—head and neck cancer	0.0212	0.0258	CcSEcCtD
Quinidine barbiturate—Lupus erythematosus—Hydroxyurea—head and neck cancer	0.0186	0.0227	CcSEcCtD
Quinidine barbiturate—Gastric irritation—Hydroxyurea—head and neck cancer	0.0179	0.0218	CcSEcCtD
Quinidine barbiturate—Cardiotoxicity—Docetaxel—head and neck cancer	0.0153	0.0186	CcSEcCtD
Quinidine barbiturate—Allergic contact dermatitis—Fluorouracil—head and neck cancer	0.0143	0.0174	CcSEcCtD
Quinidine barbiturate—Epigastric discomfort—Hydroxyurea—head and neck cancer	0.0132	0.0161	CcSEcCtD
Quinidine barbiturate—Developmental delay—Fluorouracil—head and neck cancer	0.0131	0.016	CcSEcCtD
Quinidine barbiturate—Congenital anomaly—Fluorouracil—head and neck cancer	0.0131	0.016	CcSEcCtD
Quinidine barbiturate—Systemic lupus erythematosus—Hydroxyurea—head and neck cancer	0.0125	0.0153	CcSEcCtD
Quinidine barbiturate—Gastrointestinal symptom NOS—Hydroxyurea—head and neck cancer	0.0118	0.0144	CcSEcCtD
Quinidine barbiturate—Quinine—CYP1A1—head and neck cancer	0.0117	0.439	CrCbGaD
Quinidine barbiturate—Nystagmus—Vinblastine—head and neck cancer	0.0107	0.013	CcSEcCtD
Quinidine barbiturate—Quinidine—CYP1A1—head and neck cancer	0.0103	0.386	CrCbGaD
Quinidine barbiturate—Disseminated intravascular coagulation—Docetaxel—head and neck cancer	0.0101	0.0123	CcSEcCtD
Quinidine barbiturate—Lupus erythematosus—Docetaxel—head and neck cancer	0.00968	0.0118	CcSEcCtD
Quinidine barbiturate—Blister—Hydroxyurea—head and neck cancer	0.00963	0.0117	CcSEcCtD
Quinidine barbiturate—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.00899	0.0109	CcSEcCtD
Quinidine barbiturate—Extravasation—Vinblastine—head and neck cancer	0.00872	0.0106	CcSEcCtD
Quinidine barbiturate—Gastrointestinal symptom NOS—Fluorouracil—head and neck cancer	0.0085	0.0104	CcSEcCtD
Quinidine barbiturate—Photophobia—Vinblastine—head and neck cancer	0.00715	0.0087	CcSEcCtD
Quinidine barbiturate—Nystagmus—Fluorouracil—head and neck cancer	0.00699	0.00852	CcSEcCtD
Quinidine barbiturate—Blister—Fluorouracil—head and neck cancer	0.00693	0.00844	CcSEcCtD
Quinidine barbiturate—Systemic lupus erythematosus—Docetaxel—head and neck cancer	0.00651	0.00793	CcSEcCtD
Quinidine barbiturate—Necrosis—Fluorouracil—head and neck cancer	0.00637	0.00775	CcSEcCtD
Quinidine barbiturate—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.00618	0.00753	CcSEcCtD
Quinidine barbiturate—Deafness—Vinblastine—head and neck cancer	0.00618	0.00752	CcSEcCtD
Quinidine barbiturate—Extravasation—Fluorouracil—head and neck cancer	0.00573	0.00698	CcSEcCtD
Quinidine barbiturate—Disorientation—Hydroxyurea—head and neck cancer	0.00563	0.00686	CcSEcCtD
Quinidine barbiturate—Renal failure acute—Hydroxyurea—head and neck cancer	0.00546	0.00665	CcSEcCtD
Quinidine barbiturate—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00527	0.00642	CcSEcCtD
Quinidine barbiturate—Dermatitis contact—Fluorouracil—head and neck cancer	0.00494	0.00601	CcSEcCtD
Quinidine barbiturate—Scotoma—Docetaxel—head and neck cancer	0.00475	0.00578	CcSEcCtD
Quinidine barbiturate—Photophobia—Fluorouracil—head and neck cancer	0.00469	0.00571	CcSEcCtD
Quinidine barbiturate—Hepatotoxicity—Docetaxel—head and neck cancer	0.00467	0.00569	CcSEcCtD
Quinidine barbiturate—Phenobarbital—CYP1A1—head and neck cancer	0.00466	0.175	CrCbGaD
Quinidine barbiturate—Angina pectoris—Vinblastine—head and neck cancer	0.00465	0.00567	CcSEcCtD
Quinidine barbiturate—Necrosis—Docetaxel—head and neck cancer	0.00459	0.0056	CcSEcCtD
Quinidine barbiturate—Oesophagitis—Fluorouracil—head and neck cancer	0.00457	0.00556	CcSEcCtD
Quinidine barbiturate—Coma—Fluorouracil—head and neck cancer	0.00457	0.00556	CcSEcCtD
Quinidine barbiturate—Breast disorder—Hydroxyurea—head and neck cancer	0.00455	0.00555	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Vinblastine—head and neck cancer	0.00454	0.00552	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Hydroxyurea—head and neck cancer	0.00414	0.00504	CcSEcCtD
Quinidine barbiturate—Extravasation—Docetaxel—head and neck cancer	0.00413	0.00503	CcSEcCtD
Quinidine barbiturate—Photosensitivity—Fluorouracil—head and neck cancer	0.00413	0.00503	CcSEcCtD
Quinidine barbiturate—Neutropenia—Hydroxyurea—head and neck cancer	0.00407	0.00496	CcSEcCtD
Quinidine barbiturate—Disorientation—Fluorouracil—head and neck cancer	0.00405	0.00494	CcSEcCtD
Quinidine barbiturate—Bone disorder—Docetaxel—head and neck cancer	0.00399	0.00486	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Vinblastine—head and neck cancer	0.00397	0.00484	CcSEcCtD
Quinidine barbiturate—Oliguria—Docetaxel—head and neck cancer	0.00391	0.00477	CcSEcCtD
Quinidine barbiturate—Drowsiness—Hydroxyurea—head and neck cancer	0.00388	0.00473	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Vinblastine—head and neck cancer	0.00384	0.00468	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Vinblastine—head and neck cancer	0.00382	0.00466	CcSEcCtD
Quinidine barbiturate—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00379	0.00462	CcSEcCtD
Quinidine barbiturate—Hearing impaired—Docetaxel—head and neck cancer	0.00379	0.00461	CcSEcCtD
Quinidine barbiturate—Lethargy—Fluorouracil—head and neck cancer	0.0037	0.00451	CcSEcCtD
Quinidine barbiturate—Respiratory failure—Docetaxel—head and neck cancer	0.00367	0.00447	CcSEcCtD
Quinidine barbiturate—Hepatocellular injury—Docetaxel—head and neck cancer	0.00361	0.00439	CcSEcCtD
Quinidine barbiturate—Injection site reaction—Docetaxel—head and neck cancer	0.00359	0.00437	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Hydroxyurea—head and neck cancer	0.0035	0.00427	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Hydroxyurea—head and neck cancer	0.00349	0.00425	CcSEcCtD
Quinidine barbiturate—Hallucination—Hydroxyurea—head and neck cancer	0.00347	0.00422	CcSEcCtD
Quinidine barbiturate—Irritability—Fluorouracil—head and neck cancer	0.00346	0.00422	CcSEcCtD
Quinidine barbiturate—Cardiac arrest—Fluorouracil—head and neck cancer	0.00345	0.0042	CcSEcCtD
Quinidine barbiturate—Ataxia—Fluorouracil—head and neck cancer	0.00341	0.00415	CcSEcCtD
Quinidine barbiturate—Oesophagitis—Docetaxel—head and neck cancer	0.0033	0.00401	CcSEcCtD
Quinidine barbiturate—Pulmonary oedema—Docetaxel—head and neck cancer	0.00321	0.00391	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Fluorouracil—head and neck cancer	0.0032	0.0039	CcSEcCtD
Quinidine barbiturate—Chills—Hydroxyurea—head and neck cancer	0.00313	0.00381	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Fluorouracil—head and neck cancer	0.00305	0.00372	CcSEcCtD
Quinidine barbiturate—Erythema—Hydroxyurea—head and neck cancer	0.00303	0.0037	CcSEcCtD
Quinidine barbiturate—Vertigo—Vinblastine—head and neck cancer	0.00299	0.00364	CcSEcCtD
Quinidine barbiturate—Leukopenia—Vinblastine—head and neck cancer	0.00298	0.00363	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Fluorouracil—head and neck cancer	0.00298	0.00363	CcSEcCtD
Quinidine barbiturate—Deafness—Docetaxel—head and neck cancer	0.00293	0.00356	CcSEcCtD
Quinidine barbiturate—Convulsion—Vinblastine—head and neck cancer	0.00288	0.00351	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00286	0.00349	CcSEcCtD
Quinidine barbiturate—Visual disturbance—Docetaxel—head and neck cancer	0.00276	0.00336	CcSEcCtD
Quinidine barbiturate—Renal impairment—Docetaxel—head and neck cancer	0.00275	0.00335	CcSEcCtD
Quinidine barbiturate—Dermatitis bullous—Docetaxel—head and neck cancer	0.00274	0.00334	CcSEcCtD
Quinidine barbiturate—Leukopenia—Hydroxyurea—head and neck cancer	0.00272	0.00331	CcSEcCtD
Quinidine barbiturate—Lethargy—Docetaxel—head and neck cancer	0.00267	0.00325	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Vinblastine—head and neck cancer	0.00266	0.00324	CcSEcCtD
Quinidine barbiturate—Convulsion—Hydroxyurea—head and neck cancer	0.00263	0.0032	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Fluorouracil—head and neck cancer	0.00261	0.00318	CcSEcCtD
Quinidine barbiturate—Anorexia—Vinblastine—head and neck cancer	0.00259	0.00315	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00257	0.00313	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Fluorouracil—head and neck cancer	0.00252	0.00307	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Fluorouracil—head and neck cancer	0.00251	0.00306	CcSEcCtD
Quinidine barbiturate—Oedema—Hydroxyurea—head and neck cancer	0.00248	0.00302	CcSEcCtD
Quinidine barbiturate—Ataxia—Docetaxel—head and neck cancer	0.00246	0.003	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00243	0.00296	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00242	0.00295	CcSEcCtD
Quinidine barbiturate—Liver function test abnormal—Docetaxel—head and neck cancer	0.00242	0.00294	CcSEcCtD
Quinidine barbiturate—Skin disorder—Hydroxyurea—head and neck cancer	0.00241	0.00293	CcSEcCtD
Quinidine barbiturate—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00239	0.00291	CcSEcCtD
Quinidine barbiturate—Abdominal pain upper—Docetaxel—head and neck cancer	0.00239	0.00291	CcSEcCtD
Quinidine barbiturate—Breast disorder—Docetaxel—head and neck cancer	0.00237	0.00288	CcSEcCtD
Quinidine barbiturate—Anorexia—Hydroxyurea—head and neck cancer	0.00236	0.00288	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Vinblastine—head and neck cancer	0.00236	0.00288	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00236	0.00287	CcSEcCtD
Quinidine barbiturate—Constipation—Vinblastine—head and neck cancer	0.00232	0.00283	CcSEcCtD
Quinidine barbiturate—Pain—Vinblastine—head and neck cancer	0.00232	0.00283	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Vinblastine—head and neck cancer	0.00224	0.00273	CcSEcCtD
Quinidine barbiturate—Bronchospasm—Docetaxel—head and neck cancer	0.00223	0.00271	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00222	0.0027	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Hydroxyurea—head and neck cancer	0.00221	0.00269	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Docetaxel—head and neck cancer	0.0022	0.00268	CcSEcCtD
Quinidine barbiturate—Somnolence—Hydroxyurea—head and neck cancer	0.0022	0.00268	CcSEcCtD
Quinidine barbiturate—Erythema—Fluorouracil—head and neck cancer	0.00218	0.00266	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Hydroxyurea—head and neck cancer	0.00215	0.00262	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Docetaxel—head and neck cancer	0.00215	0.00262	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Vinblastine—head and neck cancer	0.00215	0.00261	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00214	0.0026	CcSEcCtD
Quinidine barbiturate—Constipation—Hydroxyurea—head and neck cancer	0.00212	0.00258	CcSEcCtD
Quinidine barbiturate—Pain—Hydroxyurea—head and neck cancer	0.00212	0.00258	CcSEcCtD
Quinidine barbiturate—Neutropenia—Docetaxel—head and neck cancer	0.00212	0.00258	CcSEcCtD
Quinidine barbiturate—Vision blurred—Fluorouracil—head and neck cancer	0.00206	0.00251	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00204	0.00249	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Vinblastine—head and neck cancer	0.002	0.00244	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.002	0.00244	CcSEcCtD
Quinidine barbiturate—Renal failure—Docetaxel—head and neck cancer	0.00198	0.00242	CcSEcCtD
Quinidine barbiturate—Jaundice—Docetaxel—head and neck cancer	0.00197	0.0024	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Hydroxyurea—head and neck cancer	0.00196	0.00238	CcSEcCtD
Quinidine barbiturate—Leukopenia—Fluorouracil—head and neck cancer	0.00196	0.00238	CcSEcCtD
Quinidine barbiturate—Asthenia—Vinblastine—head and neck cancer	0.00195	0.00237	CcSEcCtD
Quinidine barbiturate—Convulsion—Fluorouracil—head and neck cancer	0.00189	0.00231	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Docetaxel—head and neck cancer	0.00188	0.00229	CcSEcCtD
Quinidine barbiturate—Myalgia—Fluorouracil—head and neck cancer	0.00186	0.00227	CcSEcCtD
Quinidine barbiturate—Chest pain—Fluorouracil—head and neck cancer	0.00186	0.00227	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Vinblastine—head and neck cancer	0.00186	0.00226	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00182	0.00222	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Docetaxel—head and neck cancer	0.00182	0.00222	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Docetaxel—head and neck cancer	0.00181	0.00221	CcSEcCtD
Quinidine barbiturate—Hepatitis—Docetaxel—head and neck cancer	0.00181	0.00221	CcSEcCtD
Quinidine barbiturate—Confusional state—Fluorouracil—head and neck cancer	0.0018	0.00219	CcSEcCtD
Quinidine barbiturate—Dizziness—Vinblastine—head and neck cancer	0.0018	0.00219	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Docetaxel—head and neck cancer	0.00179	0.00218	CcSEcCtD
Quinidine barbiturate—Oedema—Fluorouracil—head and neck cancer	0.00178	0.00217	CcSEcCtD
Quinidine barbiturate—Asthenia—Hydroxyurea—head and neck cancer	0.00178	0.00216	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Docetaxel—head and neck cancer	0.00178	0.00216	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Fluorouracil—head and neck cancer	0.00175	0.00213	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00175	0.00213	CcSEcCtD
Quinidine barbiturate—Visual impairment—Docetaxel—head and neck cancer	0.00175	0.00213	CcSEcCtD
Quinidine barbiturate—Tachycardia—Fluorouracil—head and neck cancer	0.00174	0.00212	CcSEcCtD
Quinidine barbiturate—Vomiting—Vinblastine—head and neck cancer	0.00173	0.0021	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Docetaxel—head and neck cancer	0.00171	0.00209	CcSEcCtD
Quinidine barbiturate—Headache—Vinblastine—head and neck cancer	0.0017	0.00207	CcSEcCtD
Quinidine barbiturate—Anorexia—Fluorouracil—head and neck cancer	0.0017	0.00207	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Hydroxyurea—head and neck cancer	0.00169	0.00206	CcSEcCtD
Quinidine barbiturate—Eye disorder—Docetaxel—head and neck cancer	0.00169	0.00206	CcSEcCtD
Quinidine barbiturate—Flushing—Docetaxel—head and neck cancer	0.00168	0.00205	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Docetaxel—head and neck cancer	0.00168	0.00205	CcSEcCtD
Quinidine barbiturate—Hypotension—Fluorouracil—head and neck cancer	0.00167	0.00203	CcSEcCtD
Quinidine barbiturate—Dizziness—Hydroxyurea—head and neck cancer	0.00164	0.00199	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Docetaxel—head and neck cancer	0.00164	0.00199	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Docetaxel—head and neck cancer	0.00163	0.00199	CcSEcCtD
Quinidine barbiturate—Chills—Docetaxel—head and neck cancer	0.00162	0.00198	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00162	0.00198	CcSEcCtD
Quinidine barbiturate—Nausea—Vinblastine—head and neck cancer	0.00161	0.00196	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Fluorouracil—head and neck cancer	0.00159	0.00194	CcSEcCtD
Quinidine barbiturate—Mental disorder—Docetaxel—head and neck cancer	0.00159	0.00193	CcSEcCtD
Quinidine barbiturate—Somnolence—Fluorouracil—head and neck cancer	0.00158	0.00193	CcSEcCtD
Quinidine barbiturate—Erythema—Docetaxel—head and neck cancer	0.00158	0.00192	CcSEcCtD
Quinidine barbiturate—Malnutrition—Docetaxel—head and neck cancer	0.00158	0.00192	CcSEcCtD
Quinidine barbiturate—Vomiting—Hydroxyurea—head and neck cancer	0.00157	0.00192	CcSEcCtD
Quinidine barbiturate—Rash—Hydroxyurea—head and neck cancer	0.00156	0.0019	CcSEcCtD
Quinidine barbiturate—Dermatitis—Hydroxyurea—head and neck cancer	0.00156	0.0019	CcSEcCtD
Quinidine barbiturate—Headache—Hydroxyurea—head and neck cancer	0.00155	0.00189	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Fluorouracil—head and neck cancer	0.00155	0.00189	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00154	0.00187	CcSEcCtD
Quinidine barbiturate—Pain—Fluorouracil—head and neck cancer	0.00152	0.00186	CcSEcCtD
Quinidine barbiturate—Nausea—Hydroxyurea—head and neck cancer	0.00147	0.00179	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Fluorouracil—head and neck cancer	0.00147	0.00179	CcSEcCtD
Quinidine barbiturate—Urticaria—Fluorouracil—head and neck cancer	0.00142	0.00172	CcSEcCtD
Quinidine barbiturate—Syncope—Docetaxel—head and neck cancer	0.00141	0.00172	CcSEcCtD
Quinidine barbiturate—Leukopenia—Docetaxel—head and neck cancer	0.00141	0.00172	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Fluorouracil—head and neck cancer	0.00141	0.00172	CcSEcCtD
Quinidine barbiturate—Palpitations—Docetaxel—head and neck cancer	0.00139	0.0017	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Docetaxel—head and neck cancer	0.00139	0.00169	CcSEcCtD
Quinidine barbiturate—Convulsion—Docetaxel—head and neck cancer	0.00137	0.00166	CcSEcCtD
Quinidine barbiturate—Myalgia—Docetaxel—head and neck cancer	0.00134	0.00163	CcSEcCtD
Quinidine barbiturate—Arthralgia—Docetaxel—head and neck cancer	0.00134	0.00163	CcSEcCtD
Quinidine barbiturate—Chest pain—Docetaxel—head and neck cancer	0.00134	0.00163	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00133	0.00162	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Fluorouracil—head and neck cancer	0.00131	0.0016	CcSEcCtD
Quinidine barbiturate—Confusional state—Docetaxel—head and neck cancer	0.0013	0.00158	CcSEcCtD
Quinidine barbiturate—Oedema—Docetaxel—head and neck cancer	0.00129	0.00157	CcSEcCtD
Quinidine barbiturate—Shock—Docetaxel—head and neck cancer	0.00127	0.00154	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Docetaxel—head and neck cancer	0.00126	0.00154	CcSEcCtD
Quinidine barbiturate—Pruritus—Fluorouracil—head and neck cancer	0.00126	0.00154	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Docetaxel—head and neck cancer	0.00126	0.00153	CcSEcCtD
Quinidine barbiturate—Tachycardia—Docetaxel—head and neck cancer	0.00126	0.00153	CcSEcCtD
Quinidine barbiturate—Skin disorder—Docetaxel—head and neck cancer	0.00125	0.00152	CcSEcCtD
Quinidine barbiturate—Anorexia—Docetaxel—head and neck cancer	0.00123	0.00149	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Fluorouracil—head and neck cancer	0.00122	0.00149	CcSEcCtD
Quinidine barbiturate—Hypotension—Docetaxel—head and neck cancer	0.0012	0.00146	CcSEcCtD
Quinidine barbiturate—Dizziness—Fluorouracil—head and neck cancer	0.00118	0.00144	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00117	0.00143	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Docetaxel—head and neck cancer	0.00115	0.0014	CcSEcCtD
Quinidine barbiturate—Somnolence—Docetaxel—head and neck cancer	0.00114	0.00139	CcSEcCtD
Quinidine barbiturate—Vomiting—Fluorouracil—head and neck cancer	0.00113	0.00138	CcSEcCtD
Quinidine barbiturate—Rash—Fluorouracil—head and neck cancer	0.00112	0.00137	CcSEcCtD
Quinidine barbiturate—Dermatitis—Fluorouracil—head and neck cancer	0.00112	0.00137	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Docetaxel—head and neck cancer	0.00112	0.00136	CcSEcCtD
Quinidine barbiturate—Headache—Fluorouracil—head and neck cancer	0.00112	0.00136	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00111	0.00135	CcSEcCtD
Quinidine barbiturate—Constipation—Docetaxel—head and neck cancer	0.0011	0.00134	CcSEcCtD
Quinidine barbiturate—Pain—Docetaxel—head and neck cancer	0.0011	0.00134	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Docetaxel—head and neck cancer	0.00106	0.00129	CcSEcCtD
Quinidine barbiturate—Nausea—Fluorouracil—head and neck cancer	0.00106	0.00129	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00105	0.00128	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Docetaxel—head and neck cancer	0.00102	0.00124	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Docetaxel—head and neck cancer	0.00102	0.00124	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Docetaxel—head and neck cancer	0.000948	0.00115	CcSEcCtD
Quinidine barbiturate—Asthenia—Docetaxel—head and neck cancer	0.000923	0.00112	CcSEcCtD
Quinidine barbiturate—Pruritus—Docetaxel—head and neck cancer	0.00091	0.00111	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Docetaxel—head and neck cancer	0.00088	0.00107	CcSEcCtD
Quinidine barbiturate—Dizziness—Docetaxel—head and neck cancer	0.000851	0.00104	CcSEcCtD
Quinidine barbiturate—Vomiting—Docetaxel—head and neck cancer	0.000818	0.000996	CcSEcCtD
Quinidine barbiturate—Rash—Docetaxel—head and neck cancer	0.000811	0.000988	CcSEcCtD
Quinidine barbiturate—Dermatitis—Docetaxel—head and neck cancer	0.00081	0.000987	CcSEcCtD
Quinidine barbiturate—Headache—Docetaxel—head and neck cancer	0.000806	0.000982	CcSEcCtD
Quinidine barbiturate—Nausea—Docetaxel—head and neck cancer	0.000764	0.000931	CcSEcCtD
